Preclinical Testing of Ciclesonide Alone and in Combination Therapy as Novel Tocolytics to Delay Delivery and Improve Neonatal Outcomes
Monday, May 6, 2024
8:45 AM – 9:00 AM ET
Location: Metro Toronto Convention Centre: 204
Publication Number: 3060.3
Alexus J. Brown, Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, TN, United States; Shajila Siricilla, Vanderbilt University Medical Center, Nashville, TN, United States; Christopher J. Hansen, Vanderbilt University School of Medicine, Nashville, TN, United States; Jeremy Staub, Vanderbilt University School of Medicine, Nashville, TN, United States; Jordan A. Walker, Vanderbilt University, Nashville, TN, United States; Jeff Reese, Vanderbilt University School of Medicine, Nashville, TN, United States; Jennifer Herington, Vanderbilt University School of Medicine, Nashville, TN, United States; John T. Benjamin, Vanderbilt University School of Medicine, NAshville, TN, United States
Presenting Author(s)
Alexus J. Brown, BS
Research Assistant Monroe Carell Jr. Children's Hospital at Vanderbilt Nashville, Tennessee, United States
Disclosure(s):
Alexus J. Brown, BS: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Shajila Siricilla, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Christopher J. Hansen, BA, BS: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Jeremy Staub, Master's in Laboratory Investigation: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Jordan A. Walker, n/a: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Jeff Reese, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Jennifer Herington, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
John T. Benjamin, MBBS. MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.